N/A N=91 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
Heart Septal Defects, Ventricular
Primary: Closure of Muscular Ventricular Septal Defects — 91 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=6,274 Comparing Types of Implementation of a Shared Decision Making Intervention
Asthma
Primary: Patient Perception of Shared Decision Making — 34; 40; 86; 79 Participants
N/A N=100 Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)
Critical Limb Ischemia
Primary: Asses the Prevalence of High On-treatment Platelet Reactivity in Critical Limb Ischemia Patients Treated With Aspirin and Clopidogrel. — 18; 17; 8; 57 Participants
Phase 4 N=46 Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
Rosacea
Primary: Percentage of Participants With Adverse Events (AE) and Serious Adverse Events (SAE) — 5; 0 Participants
N/A N=6 Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS)
Multiple Sclerosis
Primary: Trunk Impairment Scale (TIS) — 0.82; 2.58; 1.47; 1.63 percentage of change
N/A N=414 A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines
Immunologic Tests
Primary: Percentage of Subjects With Anti-H1 Stalk Enzyme-linked Immunosorbent Assay (ELISA) Antibody Concentration Equal or Above the Cut-off of 66 EU/mL - Adult Q-PAN H1N1-019…
N/A N=21 Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
Ataxia, Cerebellar · Cerebellar Ataxia · Spinocerebellar Ataxias
Primary: Change in the International Cooperative Ataxia Rating Scale (ICARS) Score From Baseline — 53.0; 52.7; 43.0; 52.1 units on a scale — p=<0.001
N/A N=85 Repeated Versus Varied Simulation Scenarios to Teach Medical Students the Management of a Pediatric Asthma Exacerbation
Education, Medical
Primary: Management Score on Transfer Scenario n°1 — 8.3; 8.0 units on a scale
Phase 3 N=996 Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
Psoriatic Arthritis
Primary: Percentage of Participants With Active Psoriatic Arthritis (PsA) Achieving an American College of Rheumatology Response 20 (ACR20) at Week 16 — 59.5; 55.5; 62.6; 27.4…
Phase 3 N=306 A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in Trough (Pre-bronchodilator) Forced Expiratory Volume in 1 Second (FEV1) on Treatment Day 169 — -0.022; 0.131 Liters — p=<0.001
Phase 3 N=218 Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).
Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis
Primary: Change From Baseline in Lymphocyte Subsets Counts up to 48 Weeks: T Cell, B Cell, Natural Killer Cell (TBNK) — 235.9; -18.8; -48.2; -65.9 cells per cubic millimeter…
N/A N=333,664 Anticoagulant Utilization Pattern
Atrial Fibrillation
Primary: Description of the Characteristics of Anticoagulant Initiators — 3.41; 4.30; 3.59; 3.82 Scores on a scale
N/A N=14,124 Drug Utilization Study for Olodaterol
Pulmonary Disease, Chronic Obstructive
Primary: Percentage of Off-label Use of Olodaterol Among New Users — 48.6; 19.6; 30.3; 33.9 Percentage of participants
N/A N=24 Effects of Unloader Bracing in Clinical Outcome and Cartilage Physiology Following Microfracture of Chondral Defects
Cartilage Loss · Microfracture
Primary: Knee Injury and Osteoarthritis Outcome Score (KOOS) (Clinical Outcome) — 12.0; 4.1; 19.1; 8.1 units on a scale — p=0.162
N/A N=600 Hydrogel Endovascular Aneurysm Treatment Trial
Cerebral Aneurysm
Primary: Number of Patients With Aneurysm Recurrence Post Surgery — 11; 41 participants — p=0.002